In the Margins
In its annual report, Sequoia Fund manager Ruane, Cuniff & Goldfarb has vented about Valeant Pharmaceuticals' recent stock plunge, though it offers an optimistic outlook for the stock. The letter outlines how much Valeant’s relationship with affiliated pharmacy Philidor wreaked havoc for the fund company. Read the original story from Barron's.
Most Read
Investment Company Institute CEO Eric Pan came out swinging on Tuesday, delivering keynote remarks to 2024 Investment Management Conference attendees in which he railed against "over-regulation" and vowed ...
A senior member of the Securities and Exchange Commission's Division of Investment Management on Monday indicated to mutual fund industry professionals that the Commission will not ...
Today is International Women's Day, and there's plenty to celebrate in the mutual fund governance space. Women have made strides in recent years in getting into ...
William Birdthistle is leaving the Securities and Exchange Commission after just over two years as director of the Division of Investment Management, the agency said on ...